Cargando…

Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials

Detalles Bibliográficos
Autores principales: le Coutre, P D, Hughes, T P, Mahon, F-X, Kim, D-W, Steegmann, J L, Shah, N P, Gooden, K, Wallis, N, Cortes, J E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935977/
https://www.ncbi.nlm.nih.gov/pubmed/26686247
http://dx.doi.org/10.1038/leu.2015.352
_version_ 1782441493350318080
author le Coutre, P D
Hughes, T P
Mahon, F-X
Kim, D-W
Steegmann, J L
Shah, N P
Gooden, K
Wallis, N
Cortes, J E
author_facet le Coutre, P D
Hughes, T P
Mahon, F-X
Kim, D-W
Steegmann, J L
Shah, N P
Gooden, K
Wallis, N
Cortes, J E
author_sort le Coutre, P D
collection PubMed
description
format Online
Article
Text
id pubmed-4935977
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49359772016-07-18 Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials le Coutre, P D Hughes, T P Mahon, F-X Kim, D-W Steegmann, J L Shah, N P Gooden, K Wallis, N Cortes, J E Leukemia Letter to the Editor Nature Publishing Group 2016-07 2016-01-12 /pmc/articles/PMC4935977/ /pubmed/26686247 http://dx.doi.org/10.1038/leu.2015.352 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Letter to the Editor
le Coutre, P D
Hughes, T P
Mahon, F-X
Kim, D-W
Steegmann, J L
Shah, N P
Gooden, K
Wallis, N
Cortes, J E
Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials
title Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials
title_full Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials
title_fullStr Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials
title_full_unstemmed Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials
title_short Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials
title_sort low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935977/
https://www.ncbi.nlm.nih.gov/pubmed/26686247
http://dx.doi.org/10.1038/leu.2015.352
work_keys_str_mv AT lecoutrepd lowincidenceofperipheralarterialdiseaseinpatientsreceivingdasatinibinclinicaltrials
AT hughestp lowincidenceofperipheralarterialdiseaseinpatientsreceivingdasatinibinclinicaltrials
AT mahonfx lowincidenceofperipheralarterialdiseaseinpatientsreceivingdasatinibinclinicaltrials
AT kimdw lowincidenceofperipheralarterialdiseaseinpatientsreceivingdasatinibinclinicaltrials
AT steegmannjl lowincidenceofperipheralarterialdiseaseinpatientsreceivingdasatinibinclinicaltrials
AT shahnp lowincidenceofperipheralarterialdiseaseinpatientsreceivingdasatinibinclinicaltrials
AT goodenk lowincidenceofperipheralarterialdiseaseinpatientsreceivingdasatinibinclinicaltrials
AT wallisn lowincidenceofperipheralarterialdiseaseinpatientsreceivingdasatinibinclinicaltrials
AT cortesje lowincidenceofperipheralarterialdiseaseinpatientsreceivingdasatinibinclinicaltrials